News & Events
Press Releases
View our latest company updates.
- Tessellate BIO Announces Appointment of Lara Boyd as Chief Business Officer 04 November 2024
- Tessellate BIO, Omico and CMRI announce a multi-year collaboration to accelerate discovery of synthetic lethal precision therapies to address ‘ALT’ cancers 30 September 2024
- Tessellate BIO Announces Appointment of Professor Sandra Strauss to Scientific Advisory Board 01 May 2024
- Tessellate BIO, an Emerging Precision Oncology Company Announces the Appointment of World-Leading Scientists to its Scientific Advisory Board 15 November 2023
- Tessellate BIO Emerges from Stealth 17 October 2023
Events
There are currently no upcoming events
In the news
The Promise of Synthetic Lethality in Precision Oncology
1 September 2024
Drug Discovery World
Download article
Tessellate Bio draws $8.4M in seed to try alternative synthetic lethality approach
8 December 2023
BioWorld
View story [Behind a paywall]
Emerging From Stealth Mode, Tesselate Bio Looks To Develop Next-Gen Synthetic Lethality Drugs
17 October 2023
Scrip
View story [Behind a paywall]
The Netherlands: Tessellate BIO emerges from stealth
17 October 2023
Investors in Healthcare
View story [Behind a paywall]
© Tessellate Bio
